Open-Label Individual Patient Study of Epstein-Barr Virus (EBV) Specific T-Cell Lines for the Treatment of a Lymphoproliferative Disease and Hemophagocytic Syndrome Associated With EBV
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Single-patient trial aiming to provide immunological consolidation following allogeneic stem cell transplantation to a young adult patient suffering from a systemic EBV-positive lymphoma of childhood.
Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:
• Capacity to provide informed consent
• Age ≥ 18
• Negative serum pregnancy test and use of effective contraception method.
Locations
Other Locations
Canada
Ciusss-Emtl
RECRUITING
Montreal
Contact Information
Primary
Jean-Sébastien Delisle, MD, PhD
js.delisle@umontreal.ca
514-252-3400
Time Frame
Start Date: 2024-01-16
Estimated Completion Date: 2025-04-05
Participants
Target number of participants: 1
Related Therapeutic Areas
Sponsors
Leads: Ciusss de L'Est de l'Île de Montréal